Pro-inflammatory Cytokine Panel Screening Service
Our Pro-inflammatory Cytokine Panel Screening Service provides an advanced platform for studying the role of pro-inflammatory cytokines in disease pathogenesis, particularly in autoimmune disorders, cancer, and chronic inflammatory conditions. Numerous disorders are linked to the dysregulation of cytokines, which are important regulators of immunological responses. By identifying and profiling pro-inflammatory cytokines, this service helps researchers discover novel therapeutic targets, identify biomarkers for disease progression, and evaluate potential drug candidates that modulate cytokine activity.
Pro-inflammatory Cytokines
Pro-inflammatory cytokines are small signaling molecules secreted by various immune cells, including macrophages, T-cells, and dendritic cells. These cytokines play pivotal roles in modulating immune cell recruitment, activation, and tissue inflammation. Key pro-inflammatory cytokines include:
-
TNF-α (Tumor Necrosis Factor-alpha): A major mediator of inflammation and cell death, elevated in conditions like rheumatoid arthritis, inflammatory bowel disease (IBD), and sepsis.
-
IL-1β (Interleukin-1 beta): Critical for the activation of the immune system in response to infections and injuries, involved in conditions like osteoarthritis and atherosclerosis.
-
IL-6 (Interleukin-6): A pleiotropic cytokine that regulates immune responses and is involved in diseases such as rheumatoid arthritis, chronic inflammatory diseases, and cancer.
-
IL-17 (Interleukin-17): Produced by Th17 cells, it plays a key role in autoimmune diseases, including psoriasis and multiple sclerosis.
-
IFN-γ (Interferon gamma): A critical cytokine for immune responses against pathogens, also involved in autoimmune diseases such as lupus and chronic inflammatory conditions.
The dysregulation of pro-inflammatory cytokine production can drive chronic inflammation and contribute to tissue damage, making these cytokines important targets for therapeutic interventions.
Pro-inflammatory Cytokine Panel Screening Service at Creative Biolabs
Our Pro-inflammatory Cytokine Panel Screening Service offers a comprehensive approach to evaluate the impact of compounds on the production, release, and signaling of key pro-inflammatory cytokines.
Our panel includes a wide range of cytokines relevant to inflammatory and autoimmune diseases, including TNF-α, IL-1β, IL-6, IL-17, IFN-γ, and others. We assess cytokine levels in cell culture supernatants or serum/plasma samples from animal models to provide a comprehensive cytokine profile.
We simulate the immune response using immortalized cell lines and human primary immune cells, including T-cells, dendritic cells, and macrophages. These assays allow us to evaluate:
Cytokine production: Quantify the release of pro-inflammatory cytokines in response to stimuli (e.g., LPS, TNF-α).
Cytokine expression: Measure the expression of cytokine mRNA or protein levels using quantitative PCR (qPCR), ELISA, or multiplex assays.
Cell activation and proliferation: Assess the activation of immune cells, such as macrophages or T-cells, by measuring markers like CD69, CD25, or intracellular cytokine staining.
-
High-Throughput Screening (HTS)
The service supports the screening of compound libraries to identify inhibitors or modulators of pro-inflammatory cytokine release. Compounds are tested for their ability to modulate cytokine secretion, either inhibiting excessive cytokine production or enhancing cytokine release in therapeutic settings.
-
Mechanism of Action Studies
We can carry out other tests to ascertain your compounds' mode of action, such as:
Pathway analysis: Investigate the signaling pathways involved in cytokine release (e.g., NF-κB, MAPK, JAK-STAT pathways).
Gene expression profiling: Use RNA-seq or qPCR to explore how compounds affect gene expression in immune cells.
Depending on your research needs, we can customize the panel to include additional cytokines or to focus on specific diseases, such as cancer, autoimmune disorders, or infectious diseases.
Unique Features of Our Services
-
Comprehensive Cytokine Profiling: Our panel includes a broad range of cytokines, ensuring comprehensive insights into inflammatory pathways and immune responses.
-
Flexible Assays and Customization: We offer flexibility to adjust the assays based on the specific disease context or therapeutic area you are targeting.
-
High-Throughput Capability: We can screen large compound libraries or biologics to identify potential modulators of pro-inflammatory cytokine release.
-
Mechanistic Insights: Beyond screening, we provide detailed analysis of how compounds modulate pro-inflammatory cytokine pathways and cellular responses.
-
Expert Analysis: Our team of experts offers in-depth data interpretation and recommendations for further experiments, helping to accelerate the development of new immunotherapies.
Frequently Asked Questions
Q1: What types of compounds can be screened with this service?
A1: We screen a variety of compounds, including small molecules, biologics (e.g., monoclonal antibodies, cytokine inhibitors), peptides, and natural products. Our service is highly adaptable to different types of drug discovery efforts.
Q2: Do you offer both in vitro and in vivo assays?
A2: Our main area of interest is immune cell culture-based in vitro tests. However, we also support in vivo studies using animal models for more complex evaluations of compound efficacy in modulating inflammation.
Contact Us
If you're interested in learning more about our Pro-inflammatory Cytokine Panel Screening Service or would like to discuss your specific research needs, our team is ready to assist you. We can help you optimize your screening process, identify key therapeutic targets, and provide expert support throughout your drug discovery journey. Let us help you discover novel therapeutic agents by modulating the immune response with our advanced Pro-inflammatory Cytokine Panel Screening Service!
For Research Use Only | Not For Clinical Use
Download our brochure
